Mouhsin Shafi, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Transcranial Magnetic Stimulation | 25 | 2023 | 1490 | 3.490 |
Why?
|
Electroencephalography | 41 | 2023 | 6311 | 2.910 |
Why?
|
Motor Cortex | 8 | 2023 | 1013 | 2.650 |
Why?
|
Seizures | 15 | 2023 | 2998 | 1.470 |
Why?
|
Evoked Potentials, Motor | 7 | 2023 | 465 | 1.170 |
Why?
|
Theta Rhythm | 4 | 2023 | 220 | 1.020 |
Why?
|
Delirium | 9 | 2024 | 1697 | 0.930 |
Why?
|
Epilepsy | 6 | 2023 | 3327 | 0.760 |
Why?
|
Nerve Net | 8 | 2022 | 2352 | 0.730 |
Why?
|
Brain Waves | 5 | 2017 | 417 | 0.690 |
Why?
|
Alzheimer Disease | 11 | 2024 | 8761 | 0.680 |
Why?
|
Brain | 18 | 2022 | 27366 | 0.620 |
Why?
|
Evoked Potentials, Auditory | 1 | 2022 | 533 | 0.610 |
Why?
|
Periventricular Nodular Heterotopia | 2 | 2016 | 57 | 0.610 |
Why?
|
Pyramidal Tracts | 1 | 2017 | 251 | 0.500 |
Why?
|
Neuronal Plasticity | 3 | 2020 | 1448 | 0.490 |
Why?
|
Magnetic Field Therapy | 1 | 2014 | 27 | 0.460 |
Why?
|
Brain Mapping | 5 | 2020 | 6685 | 0.440 |
Why?
|
Subarachnoid Hemorrhage | 5 | 2018 | 1024 | 0.410 |
Why?
|
Cerebral Cortex | 4 | 2024 | 5813 | 0.350 |
Why?
|
Computational Biology | 1 | 2022 | 3568 | 0.330 |
Why?
|
Models, Theoretical | 3 | 2017 | 3573 | 0.330 |
Why?
|
Reproducibility of Results | 11 | 2023 | 20218 | 0.280 |
Why?
|
Affect | 1 | 2014 | 1495 | 0.270 |
Why?
|
Memory, Short-Term | 3 | 2015 | 1008 | 0.230 |
Why?
|
Humans | 64 | 2024 | 767991 | 0.210 |
Why?
|
Long-Term Potentiation | 2 | 2021 | 290 | 0.200 |
Why?
|
Young Adult | 14 | 2022 | 60048 | 0.190 |
Why?
|
Cost-Benefit Analysis | 1 | 2014 | 5536 | 0.190 |
Why?
|
Glasgow Outcome Scale | 2 | 2018 | 101 | 0.190 |
Why?
|
Epilepsy, Temporal Lobe | 2 | 2015 | 390 | 0.180 |
Why?
|
Neural Pathways | 1 | 2012 | 3113 | 0.180 |
Why?
|
Rest | 2 | 2023 | 948 | 0.170 |
Why?
|
Atrophy | 1 | 2024 | 1646 | 0.160 |
Why?
|
Male | 31 | 2024 | 364641 | 0.160 |
Why?
|
Monitoring, Physiologic | 3 | 2018 | 1798 | 0.150 |
Why?
|
Postoperative Complications | 6 | 2024 | 15831 | 0.150 |
Why?
|
Aged | 22 | 2024 | 171446 | 0.150 |
Why?
|
Evoked Potentials | 2 | 2023 | 1057 | 0.140 |
Why?
|
Epilepsies, Partial | 1 | 2021 | 435 | 0.140 |
Why?
|
Bipolar Disorder | 1 | 2014 | 5130 | 0.140 |
Why?
|
Cognitive Reserve | 1 | 2017 | 92 | 0.140 |
Why?
|
Depressive Disorder, Major | 1 | 2014 | 4818 | 0.130 |
Why?
|
Piracetam | 1 | 2017 | 88 | 0.130 |
Why?
|
Adult | 22 | 2022 | 223583 | 0.130 |
Why?
|
Female | 30 | 2024 | 397113 | 0.130 |
Why?
|
Nootropic Agents | 1 | 2017 | 159 | 0.130 |
Why?
|
Middle Aged | 22 | 2022 | 223422 | 0.120 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2019 | 12252 | 0.120 |
Why?
|
Aged, 80 and over | 9 | 2024 | 59598 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 7 | 2024 | 36742 | 0.120 |
Why?
|
Interleukin-6 | 1 | 2024 | 3228 | 0.120 |
Why?
|
Foramen Ovale | 1 | 2014 | 17 | 0.110 |
Why?
|
Brain Ischemia | 2 | 2018 | 3007 | 0.110 |
Why?
|
Pyrazines | 1 | 2020 | 1205 | 0.110 |
Why?
|
Cerebral Infarction | 1 | 2018 | 969 | 0.110 |
Why?
|
C-Reactive Protein | 1 | 2024 | 3858 | 0.100 |
Why?
|
Visual Pathways | 1 | 2017 | 558 | 0.100 |
Why?
|
Critical Care | 2 | 2017 | 2715 | 0.100 |
Why?
|
Electromyography | 1 | 2017 | 1399 | 0.100 |
Why?
|
Intelligence | 1 | 2017 | 926 | 0.100 |
Why?
|
Neurosciences | 1 | 2016 | 383 | 0.100 |
Why?
|
Amyloid beta-Peptides | 2 | 2023 | 3914 | 0.090 |
Why?
|
Neurons | 2 | 2007 | 9518 | 0.090 |
Why?
|
Haplorhini | 2 | 2007 | 523 | 0.080 |
Why?
|
Memory Disorders | 1 | 2015 | 1200 | 0.080 |
Why?
|
Executive Function | 1 | 2017 | 1401 | 0.080 |
Why?
|
Brain Diseases | 1 | 2017 | 1554 | 0.070 |
Why?
|
Early Diagnosis | 1 | 2012 | 1193 | 0.070 |
Why?
|
Cognition | 3 | 2020 | 7072 | 0.070 |
Why?
|
Retrospective Studies | 9 | 2021 | 81746 | 0.070 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2014 | 1488 | 0.070 |
Why?
|
Anticonvulsants | 2 | 2018 | 1922 | 0.070 |
Why?
|
Nervous System Diseases | 1 | 2016 | 1661 | 0.060 |
Why?
|
Treatment Outcome | 3 | 2021 | 65364 | 0.060 |
Why?
|
Intensive Care Units | 2 | 2016 | 3800 | 0.060 |
Why?
|
Extracellular Space | 1 | 2007 | 563 | 0.060 |
Why?
|
Inflammation | 1 | 2024 | 10871 | 0.060 |
Why?
|
Electrophysiology | 1 | 2007 | 1266 | 0.060 |
Why?
|
Cerebrospinal Fluid Proteins | 1 | 2023 | 71 | 0.050 |
Why?
|
Depressive Disorder | 1 | 2015 | 3721 | 0.050 |
Why?
|
Brain Injuries | 1 | 2014 | 2057 | 0.050 |
Why?
|
Prefrontal Cortex | 2 | 2015 | 2238 | 0.050 |
Why?
|
Time Factors | 4 | 2024 | 40214 | 0.050 |
Why?
|
Parietal Lobe | 1 | 2007 | 866 | 0.050 |
Why?
|
Data Interpretation, Statistical | 2 | 2013 | 2708 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39345 | 0.050 |
Why?
|
Cohort Studies | 2 | 2022 | 41749 | 0.050 |
Why?
|
Spin Labels | 1 | 2023 | 336 | 0.050 |
Why?
|
Somatosensory Cortex | 1 | 2005 | 515 | 0.050 |
Why?
|
Research Design | 1 | 2016 | 6211 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2018 | 4884 | 0.040 |
Why?
|
Oligonucleotides | 1 | 2023 | 563 | 0.040 |
Why?
|
Risk | 1 | 2012 | 9609 | 0.040 |
Why?
|
Time | 1 | 2022 | 552 | 0.040 |
Why?
|
Selection Bias | 1 | 2022 | 360 | 0.040 |
Why?
|
Hippocampus | 2 | 2023 | 3786 | 0.040 |
Why?
|
Predictive Value of Tests | 2 | 2014 | 15442 | 0.040 |
Why?
|
Mental Recall | 2 | 2017 | 1226 | 0.040 |
Why?
|
Neuromuscular Junction | 1 | 2021 | 407 | 0.040 |
Why?
|
Pilot Projects | 2 | 2022 | 8740 | 0.040 |
Why?
|
Mass Screening | 1 | 2014 | 5458 | 0.040 |
Why?
|
Amyloid | 1 | 2023 | 854 | 0.040 |
Why?
|
Algorithms | 4 | 2016 | 14163 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2018 | 14718 | 0.040 |
Why?
|
Perfusion | 1 | 2021 | 1401 | 0.030 |
Why?
|
Neuropsychological Tests | 2 | 2023 | 7140 | 0.030 |
Why?
|
Risk Factors | 2 | 2021 | 74936 | 0.030 |
Why?
|
Mental Disorders | 1 | 2016 | 6875 | 0.030 |
Why?
|
Critical Illness | 2 | 2022 | 2756 | 0.030 |
Why?
|
Fourier Analysis | 1 | 2017 | 439 | 0.030 |
Why?
|
Periodicity | 1 | 2017 | 348 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2023 | 22287 | 0.030 |
Why?
|
Positron-Emission Tomography | 2 | 2023 | 6668 | 0.030 |
Why?
|
Adolescent | 4 | 2021 | 89155 | 0.030 |
Why?
|
Aging | 2 | 2023 | 8744 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2016 | 962 | 0.030 |
Why?
|
Data Collection | 1 | 2023 | 3326 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 2013 | 367 | 0.030 |
Why?
|
Cerebrovascular Circulation | 1 | 2023 | 2726 | 0.030 |
Why?
|
Dominance, Cerebral | 1 | 2014 | 623 | 0.030 |
Why?
|
Spectrum Analysis | 1 | 2014 | 449 | 0.020 |
Why?
|
Prospective Studies | 3 | 2023 | 54924 | 0.020 |
Why?
|
Double-Blind Method | 2 | 2017 | 12464 | 0.020 |
Why?
|
Attention | 1 | 2022 | 2424 | 0.020 |
Why?
|
Verbal Learning | 1 | 2014 | 465 | 0.020 |
Why?
|
Forecasting | 1 | 2020 | 2945 | 0.020 |
Why?
|
Electrophysiological Phenomena | 1 | 2013 | 310 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2863 | 0.020 |
Why?
|
Memory | 1 | 2020 | 2208 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2017 | 2107 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2014 | 1587 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3912 | 0.020 |
Why?
|
Teaching | 1 | 2017 | 1171 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2021 | 2816 | 0.020 |
Why?
|
Electrodes, Implanted | 1 | 2014 | 836 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2023 | 5349 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2017 | 6228 | 0.020 |
Why?
|
Intracranial Aneurysm | 1 | 2018 | 1271 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2015 | 1892 | 0.020 |
Why?
|
Observer Variation | 1 | 2013 | 2618 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2013 | 2004 | 0.020 |
Why?
|
Massachusetts | 1 | 2019 | 8888 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2015 | 6029 | 0.020 |
Why?
|
Prognosis | 2 | 2018 | 29979 | 0.020 |
Why?
|
Patient Discharge | 1 | 2018 | 3476 | 0.010 |
Why?
|
Comorbidity | 1 | 2019 | 10590 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10757 | 0.010 |
Why?
|
Models, Neurological | 1 | 2013 | 1776 | 0.010 |
Why?
|
Bayes Theorem | 1 | 2011 | 2358 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8748 | 0.010 |
Why?
|
Models, Statistical | 1 | 2018 | 5107 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15867 | 0.010 |
Why?
|
Anesthesia | 1 | 2013 | 1595 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2014 | 3619 | 0.010 |
Why?
|
Oxygen | 1 | 2013 | 4269 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2016 | 14783 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 26375 | 0.010 |
Why?
|
Animals | 2 | 2007 | 169222 | 0.010 |
Why?
|
Action Potentials | 1 | 2005 | 1841 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2011 | 7445 | 0.010 |
Why?
|
Quality of Life | 1 | 2015 | 13489 | 0.010 |
Why?
|
Child | 1 | 2021 | 80906 | 0.010 |
Why?
|